How should a child with Flexabenz (cyclobenzaprine) poisoning be managed?

Management of Flexabenz (Cyclobenzaprine) Poisoning in Children

Contact a regional poison control center immediately (1-800-222-1222 in the US) and provide supportive care focused on airway protection, respiratory support, and hemodynamic stabilization, as cyclobenzaprine poisoning in children is managed primarily with standard resuscitation measures without specific antidotes. 1, 2

Immediate Stabilization and Monitoring

• Establish and maintain airway patency with bag-mask ventilation initially, advancing to endotracheal intubation if protective airway reflexes are lost or respiratory depression develops 1
• Provide continuous respiratory monitoring to prevent hypoxemia and hypercarbia, which can cause tissue injury and death 1
• Monitor for anticholinergic effects including lethargy, sinus tachycardia, and agitation, as these are the most common manifestations of cyclobenzaprine toxicity 3
• Observe for symptom onset within 4 hours of ingestion, as all symptomatic cases with known ingestion times became symptomatic within this timeframe 3

Risk Stratification by Dose

• Ingestions less than 100 mg typically do not require treatment beyond gastrointestinal decontamination 3
• Ingestions of 100 mg or greater may require supportive interventions including mechanical ventilation, vasopressor support (dopamine), fluid boluses, sedation, or urinary catheterization 3
• Severe presentations (comatose state, absent brainstem reflexes, no spontaneous respiratory effort) are rare but may occur with large ingestions 4

Key Clinical Considerations

• Cyclobenzaprine does not produce life-threatening cardiovascular or neurologic effects typical of tricyclic antidepressants in doses less than 1 gram, despite its structural similarity to amitriptyline 3
• Dysrhythmias beyond sinus tachycardia are infrequent and none are typically life-threatening 3
• Seizures have not been reported in pure cyclobenzaprine overdoses 3
• Both hypertension and hypotension may occur, though neither is typically severe 3

Antidote and Pharmacologic Management

• No specific antidote exists for cyclobenzaprine poisoning 1, 3
• Flumazenil has no role in cyclobenzaprine poisoning and should not be administered, as it may precipitate seizures and dysrhythmias in the presence of cyclic structures similar to tricyclic antidepressants 1
• Administer naloxone promptly if opioid co-ingestion is suspected, as mixed overdoses are common and opioids cause more significant respiratory depression 1

Assessment for Co-Ingestions

• Evaluate for co-ingestion with other CNS depressants (opioids, benzodiazepines, alcohol), as these combinations increase the risk of life-threatening respiratory depression 1
• Consider the presence of dysrhythmogenic drugs that could complicate management 1

Advanced Interventions for Severe Cases

• Therapeutic plasma exchange (TPE) may be considered in life-threatening cases with severe neurologic depression, recent ingestion, and failure of conventional supportive measures, though evidence is limited to case reports 4
• TPE is most effective when performed promptly after ingestion in patients with high plasma protein binding medications and long half-lives 4

Common Pitfalls to Avoid

• Do not assume tricyclic antidepressant-level toxicity based on structural similarity alone, as cyclobenzaprine is significantly less toxic 3
• Do not administer flumazenil even if benzodiazepine co-ingestion is suspected, given the cyclic structure of cyclobenzaprine and risk of precipitating seizures 1
• Do not delay naloxone administration if opioid co-ingestion is possible, as this takes priority over other considerations 1

Consultation and Expert Guidance

• Contact regional poison control centers for expert treatment guidance in all cases, particularly when co-ingestions are suspected or the clinical course is atypical 1, 5, 6
• Medical toxicologists can provide specialized advice for complex presentations or when extracorporeal toxin removal is being considered 7, 5